Tower Research Capital (TRC)’s VIVEVE MED INC VIVE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,514
| Closed | -$1K | – | 6743 |
|
|
2022
Q4 | $1K | Sell |
2,514
-193
| -7% | -$97 | ﹤0.01% | 5804 |
|
|
2022
Q3 | $2K | Sell |
2,707
-59
| -2% | -$44 | ﹤0.01% | 5695 |
|
|
2022
Q2 | $2K | Buy |
+2,766
| New | +$2.35K | ﹤0.01% | 5685 |
|
|
2022
Q1 | – | Sell |
-1,621
| Closed | -$2K | – | 6956 |
|
|
2021
Q4 | $2K | Buy |
1,621
+142
| +10% | +$261 | ﹤0.01% | 5736 |
|
|
2021
Q3 | $3K | Buy |
+1,479
| New | +$3.72K | ﹤0.01% | 5194 |
|
|
2021
Q1 | – | Sell |
-433
| Closed | -$2K | – | 5889 |
|
|
2020
Q4 | $2K | Buy |
+433
| New | +$2.18K | ﹤0.01% | 4944 |
|
|
2019
Q1 | – | Sell |
-9
| Closed | -$10K | – | 4484 |
|
|
2018
Q4 | $10K | Buy |
+9
| New | +$21.6K | ﹤0.01% | 2490 |
|
|
2018
Q2 | – | Sell |
-1
| Closed | -$3K | – | 4221 |
|
|
2018
Q1 | $3K | Buy |
+1
| New | +$4.35K | ﹤0.01% | 2894 |
|
|
2017
Q4 | – | Sell |
-4
| Closed | -$20.8K | – | 3265 |
|
|
2017
Q3 | $20K | Buy |
+4
| New | +$24.7K | ﹤0.01% | 2740 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 2542 |
|
|
2016
Q4 | – | Sell |
-1
| Closed | -$4K | – | 4565 |
|
|
2016
Q3 | $4K | Buy |
+1
| New | +$6.64K | ﹤0.01% | 2745 |
|
Other funds holding VIVE
Tower Research Capital (TRC)'s VIVE Position: Q1 2023 in Review
Tower Research Capital (TRC) sold out of VIVEVE MED INC (VIVE) in Q1 2023, closing a stake of 2,514 shares — an estimated $1K sold.
Tower Research Capital (TRC) first reported a position in VIVE in Q3 2016 and held it in 10 quarters. The position peaked at $20K in Q3 2017. 1 fund tracked by Wall St. Rank holds VIVE as of Q1 2023.
- Tower Research Capital (TRC) reported no remaining VIVEVE MED INC position as of Q1 2023 after selling out during the quarter.
- Tower Research Capital (TRC) sold 2,514 VIVEVE MED INC shares in Q1 2023, an estimated $1K.
- Tower Research Capital (TRC) first reported a position in VIVEVE MED INC in Q3 2016 and held it in 10 quarters.
- Tower Research Capital (TRC)'s VIVEVE MED INC position peaked at $20K in Q3 2017.
- 1 fund tracked by Wall St. Rank held VIVEVE MED INC as of Q1 2023.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.